top of page
Insights and News Curated for Life Science Experts by Life Science Experts....
INSIGHTS HUB
Warren Buffett’s Hiring Rule: Why Integrity Comes First
Warren Buffett’s hiring philosophy has long been quoted in business circles, and for good reason. As he prepares to step down as CEO of...
Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry
As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...
The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective
In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...
Search
Vaxart, Inc. Appoints Steven Lo as CEO
San Francisco, CA, March 06, 2024 (GlobeNewswire) -- Vaxart, Inc. (Nasdaq: VXRT) has named Steven Lo as its President and Chief...
Alumis Announces $259M Series C Financing
South San Francisco, CA, March 6, 2024 (VC News Daily) -- Alumis Inc., a pioneering clinical-stage biopharmaceutical enterprise...
ChemoMetec Appoints Martin Helbo Behrens as New CEO, Effective Immediately
Denmark, March 13, 2024 (GlobeNewswire) -- The Board of Directors of ChemoMetec appoints current COO Martin Helbo Behrens as new CEO. ...
Novartis Acquires IFM for $835M to Advance First-In-Class STING Antagonist Program Targeting the Innate Immune System
Boston, MA, March 13, 2024 (PR Newswire) -- IFM Therapeutics, a leading biopharmaceutical firm specializing in innovative therapies for...
AbbVie Announces Appointment of Robert A. Michael as CEO
North Chicago, IL, February 20, 2024 (PRNewswire) -- AbbVie (NYSE: ABBV) announced that Robert A. Michael, the current president and...
Alamar Biosciences Raises $128M in Oversubscribed Series C
Fremont, CA, February 26, 2024 (PRNewswire) -- Alamar Biosciences, a company specializing in precision proteomics for early disease...
BRIJ Medical Appoints Tim Gleeson as CEO
Marietta, GA, February 13, 2024 (PRNewswire) -- BRIJ Medical announces Tim Gleeson as CEO and Joe Andrew as Senior VP of sales. Tim...
AbbVie to Pay OSE Immunotherapeutics an Upfront Payment of $48M and Offer Potential Additional Milestone Payments of up to $665M
North Chicago, IL, and Nantes, France, February 28, 2024 (PRNewswire) -- AbbVie and OSE Immunotherapeutics announced a partnership to...
Agiliti to be taken private by THL partners with an Enterprise Value of $2.5B
Minneapolis, MN, February 28, 2024 (Reuters) -- Agiliti Inc. (NYSE:AGTI), a provider of medical technology management and service...
Procyrion successfully secures $57.7M in series E funding
Houston, February 5, 2024 (PRNewswire) -- Procyrion™, Inc., focused on enhancing patient outcomes in cardiac and renal care, has...
Catalyst Clinical Research welcomes Nik Morton as new CEO
Wilmington, NC, February 14, 2024 (PRNewswire) -- Catalyst Clinical Research appointed Nik Morton as its CEO. Stepping into the role...
Latigo Biotherapeutics launches with $135M Series A funding to advance development of non-opioid pain treatments
Thousands Oaks, CA, February 14, 2024 (PRNewswire) -- Latigo Biotherapeutics has announced that it has completed a $135 million series...
BRIJ Medical appoints Tim Gleeson as CEO
Marietta, GA, February 13, 2024 (PRNewswire) -- BRIJ Medical appointed Tim Gleeson as their new CEO. Tim brings a wealth of medical...
Gilead to buy CymaBay in $4.3B deal for liver disease drug
Foster City, CA, February 12, 2024 (Yahoo Finance) -- Gilead Sciences announces acquisition of CymaBay Therapeutics in a $4.3 billion...
Accent Therapeutics Completes $75M Series C Financing
Lexington, MA, January 23, 2024 (PRNewswire) -- Accent Therapeutics has successfully concluded its Series C financing, securing a total...
ulrich medical USA® announces Jim Bruty as its Chief Executive Officer
Plano, TX, January 24, 2024 (PRNewswire) -- ulrich medical USA, a trailblazer in expandable corpectomy devices and a prominent player...
COUR Pharmaceuticals Secures $105M in Series A Financing
Chicago, IL, January 30, 2024 (Globe Newswire) -- COUR Pharmaceuticals has secured approximately $105 million in financing, marking a...
Theragenics Corporation Welcomes Mark Pugh as New CEO
Buford, GA, January 25, 2024 (Business Wire) -- Theragenics Corporation®, has appointed Mark Pugh, as the new CEO succeeding Frank...
Sanofi to buy INBRX-101 for $2.2B
La Jolla, CA & Paris, France, January 23, 2024 (Reuters) -- Sanofi (SASY.PA) has reached an agreement to acquire U.S. Inhibrx (INBX.O)...
Comanche Biopharma Successfully Concludes Oversubscribed $75M Series B Funding Round to Propel Mission in Pioneering the First Treatment Addressing the Fundamental Cause of Preeclampsia
Concord, MA, January 17, 2024 (Globe Newswire) -- Comanche Biopharma Corp. closes an oversubscribed $75 million Series B financing,...
bottom of page